Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Apr 2009):

A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.

Full Abstract

There is a need for novel anxiolytics, which are effective, but do not cause sedation, tolerance, and rebound anxiety on discontinuation. To investigate a procedure that can be used to assess these characteristics preclinically, rats were initially trained to press a lever at a high rate to obtain food. Once trained, periods of punishment were introduced in which electric shocks were superimposed. The intensity of these electric shocks was increased every 90 s from very low (0.01 mA) to sufficiently high to stop most subjects responding (0.4 mA), so that a complete rate/intensity function was obtained during each punishment period. The benzodiazepine, chlordiazepoxide, and two novel subtype-selective gamma-aminobutyric acid-A agonists, TP003 and TPA023, significantly increased response rates mildly suppressed by intermediate levels of electric shock without any effect on unpunished response rate. Two clinically anxiogenic agents, yohimbine and flumazenil, reduced the rate of punished responding. Aripiprazole and amphetamine reduced both punished and unpunished responding. Repeated treatment with diazepam 2.5 mg/kg daily for 15 days, initially markedly reduced unpunished response rates, but also increased punished response rates, an effect which became greater with repeated treatment. Abrupt cessation of diazepam treatment produced a reduction in punished responding. Diazepam (5 mg/kg daily) produced a greater reduction in unpunished responding, a smaller increase in punished responding, and a larger and longer lasting reduction in punished rates on withdrawal. In conclusion, the procedure detected anxiolytic and anxiogenic effects of drugs, and the sedative side effects, development of tolerance, and rebound-anxiety on discontinuation of a benzodiazepine. This procedure should have utility in the characterization of novel treatments of anxiety.

 

Author information

Author/s: Evenden, John (J); Ross, Laurie (L); Jonak, Gerald (G); Zhou, Jin (J);

Affiliation: Department of Neuroscience Biology, CNS Discovery, AstraZeneca R&D Wilmington, Wilmington, Delaware, USA. john.evenden(-atsign-)wiltonlogic.com

Journal and publication information

Publication Type: Journal Article

Journal: Behavioural pharmacology (Behav Pharmacol), published in England. (Language: eng)

Reference: 2009-May; vol 20 (issue 3) : pp 226-36

Dates: Created 2009/05/20; Completed 2009/07/23;

PMID: 19455771, status: MEDLINE (last retrieval date: 8/20/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo(4,3-b)pyridazine (0) ; Anti-Anxiety Agents (0) ; Piperazines (0) ; Pyridazines (0) ; Quinolones (0) ; Triazoles (0) ; Benzodiazepines (12794-10-4) ; aripiprazole (129722-12-9) ; Yohimbine (146-48-5) ; Diazepam (439-14-5) ; Dextroamphetamine (51-64-9) ; Chlordiazepoxide (58-25-3) ; Flumazenil (78755-81-4)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

8/30/1989
3/30/1997
Higher Relevance Score (100)
Lower Relevance Score (80)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index